abstract |
The present application provides an aqueous composition for eye drops and nasal drops, which contains levocetirizine or a salt thereof as an active ingredient. One aspect of the present application contains levocetirizine or a salt thereof at a concentration of 0.05-0.5% (w/v) in terms of levocetirizine, and may further contain a surfactant and/or an organic acid salt. |